Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis

Nature Chemical Biology volume 6, pages 25–33 (2010)Cite this article

Abstract

Chemical modulation of histone deacetylase (HDAC) activity by HDAC inhibitors (HDACi) is an increasingly important approach for modifying the etiology of human disease. Loss-of-function diseases arise as a consequence of protein misfolding and degradation, which lead to system failures. The ΔF508 mutation in cystic fibrosis transmembrane conductance regulator (CFTR) results in the absence of the cell surface chloride channel and a loss of airway hydration, leading to the premature lung failure and reduced lifespan responsible for cystic fibrosis. We now show that the HDACi suberoylanilide hydroxamic acid (SAHA) restores surface channel activity in human primary airway epithelia to levels that are 28% of those of wild-type CFTR. Biological silencing of all known class I and II HDACs reveals that HDAC7 plays a central role in restoration of ΔF508 function. We suggest that the tunable capacity of HDACs can be manipulated by chemical biology to counter the onset of cystic fibrosis and other human misfolding disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: HDAC inhibitor treatment increases ΔF508 CFTR expression and trafficking.
Figure 2: Chronic low-dose SAHA treatment increases ΔF508 CFTR stability and trafficking.
Figure 3: HDAC inhibitor treatment activates ΔF508 channel activity.
Figure 4: Silencing of HDAC7 increases ΔF508 CFTR expression, trafficking and activity.
Figure 5: SAHA rescues ΔF508 CFTR activity in primary human bronchial epithelial cells.
Figure 6: Mechanism of HDAC7-mediated ΔF508 multitarget pathway correction.

Similar content being viewed by others

References

  1. Riordan, J.R. CFTR function and prospects for therapy. Annu. Rev. Biochem. 77, 701–726 (2008).

    Article  CAS  Google Scholar 

  2. Qu, B.H., Strickland, E.H. & Thomas, P.J. Localization and suppression of a kinetic defect in cystic fibrosis transmembrane conductance regulator folding. J. Biol. Chem. 272, 15739–15744 (1997).

    Article  CAS  Google Scholar 

  3. Boucher, R.C. Evidence for airway surface dehydration as the initiating event in CF airway disease. J. Intern. Med. 261, 5–16 (2007).

    Article  CAS  Google Scholar 

  4. Balch, W.E., Morimoto, R.I., Dillin, A. & Kelly, J.W. Adapting proteostasis for disease intervention. Science 319, 916–919 (2008).

    Article  CAS  Google Scholar 

  5. Powers, E.T., Morimoto, R.I., Dillin, A., Kelly, J.W. & Balch, W.E. Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78, 959–991 (2009).

    Article  CAS  Google Scholar 

  6. Hutt, D.M., Powers, E.T. & Balch, W.E. The proteostasis boundary in misfolding diseases of membrane traffic. FEBS Lett. 583, 2639–2646 (2009).

    Article  CAS  Google Scholar 

  7. Gregersen, N. Protein misfolding disorders: pathogenesis and intervention. J. Inherit. Metab. Dis. 29, 456–470 (2006).

    Article  CAS  Google Scholar 

  8. Marks, P.A. & Breslow, R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat. Biotechnol. 25, 84–90 (2007).

    Article  CAS  Google Scholar 

  9. Haberland, M., Montgomery, R.L. & Olson, E.N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32–42 (2009).

    Article  CAS  Google Scholar 

  10. Scroggins, B.T. et al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol. Cell 25, 151–159 (2007).

    Article  CAS  Google Scholar 

  11. Ozcan, U. et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137–1140 (2006).

    Article  Google Scholar 

  12. Adcock, I.M., Tsaprouni, L., Bhavsar, P. & Ito, K. Epigenetic regulation of airway inflammation. Curr. Opin. Immunol. 19, 694–700 (2007).

    Article  CAS  Google Scholar 

  13. Lin, H.S. et al. Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents. Br. J. Pharmacol. 150, 862–872 (2007).

    Article  CAS  Google Scholar 

  14. Westerheide, S.D., Anckar, J., Stevens, S.M. Jr., Sistonen, L. & Morimoto, R.I. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323, 1063–1066 (2009).

    Article  CAS  Google Scholar 

  15. Fischle, W. et al. Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J. Biol. Chem. 276, 35826–35835 (2001).

    Article  CAS  Google Scholar 

  16. Wang, X. et al. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 127, 803–815 (2006).

    Article  CAS  Google Scholar 

  17. Kovacs, J.J. et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell 18, 601–607 (2005).

    Article  CAS  Google Scholar 

  18. Bebok, Z. et al. Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers. J. Physiol. (Lond.) 569, 601–615 (2005).

    Article  CAS  Google Scholar 

  19. Lukacs, G.L. et al. Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 13, 6076–6086 (1994).

    Article  CAS  Google Scholar 

  20. Gentzsch, M. et al. Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol. Biol. Cell 15, 2684–2696 (2004).

    Article  CAS  Google Scholar 

  21. Lahm, A. et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc. Natl. Acad. Sci. USA 104, 17335–17340 (2007).

    Article  CAS  Google Scholar 

  22. Marks, P.A. & Dokmanovic, M. Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin. Investig. Drugs 14, 1497–1511 (2005).

    Article  CAS  Google Scholar 

  23. Blander, G. & Guarente, L. The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73, 417–435 (2004).

    Article  CAS  Google Scholar 

  24. Milne, J.C. & Denu, J.M. The Sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 12, 11–17 (2008).

    Article  CAS  Google Scholar 

  25. Caci, E. et al. Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis. Biochem. J. 413, 135–142 (2008).

    Article  CAS  Google Scholar 

  26. Ekins, S., Nikolsky, Y., Bugrim, A., Kirillov, E. & Nikolskaya, T. Pathway mapping tools for analysis of high content data. Methods Mol. Biol. 356, 319–350 (2007).

    CAS  PubMed  Google Scholar 

  27. Sun, F. et al. Derlin-1 promotes the efficient degradation of cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants. J. Biol. Chem. 281, 36856–36863 (2006).

    Article  CAS  Google Scholar 

  28. Wang, X., Koulov, A.V., Kellner, W.A., Riordan, J.R. & Balch, W.E. Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking. Traffic 9, 1878–1893 (2008).

    Article  CAS  Google Scholar 

  29. Wang, X. et al. COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code. J. Cell Biol. 167, 65–74 (2004).

    Article  CAS  Google Scholar 

  30. Wiseman, R.L., Powers, E.T., Buxbaum, J.N., Kelly, J.W. & Balch, W.E. An adaptable standard for protein export from the endoplasmic reticulum. Cell 131, 809–821 (2007).

    Article  CAS  Google Scholar 

  31. Guggino, W.B. & Stanton, B.A. New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat. Rev. Mol. Cell Biol. 7, 426–436 (2006).

    Article  CAS  Google Scholar 

  32. Dokmanovic, M. et al. Histone deacetylase inhibitors selectively suppress expression of HDAC7. Mol. Cancer Ther. 6, 2525–2534 (2007).

    Article  CAS  Google Scholar 

  33. Chang, S. et al. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 126, 321–334 (2006).

    Article  CAS  Google Scholar 

  34. Kasler, H.G. & Verdin, E. Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes. Mol. Cell. Biol. 27, 5184–5200 (2007).

    Article  CAS  Google Scholar 

  35. Amaral, M.D. Processing of CFTR: traversing the cellular maze–how much CFTR needs to go through to avoid cystic fibrosis? Pediatr. Pulmonol. 39, 479–491 (2005).

    Article  Google Scholar 

  36. Yoo, J.S. et al. Non-conventional trafficking of the cystic fibrosis transmembrane conductance regulator through the early secretory pathway. J. Biol. Chem. 277, 11401–11409 (2002).

    Article  CAS  Google Scholar 

  37. Mai, A. The therapeutic uses of chromatin-modifying agents. Expert Opin. Ther. Targets 11, 835–851 (2007).

    Article  CAS  Google Scholar 

  38. Herman, D. et al. Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat. Chem. Biol. 2, 551–558 (2006).

    Article  CAS  Google Scholar 

  39. Mai, A. et al. Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia. Mol. Pharmacol. 72, 1111–1123 (2007).

    Article  CAS  Google Scholar 

  40. Westphal, C.H., Dipp, M.A. & Guarente, L. A therapeutic role for sirtuins in diseases of aging? Trends Biochem. Sci. 32, 555–560 (2007).

    Article  CAS  Google Scholar 

  41. Bates, E.A., Victor, M., Jones, A.K., Shi, Y. & Hart, A.C. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. J. Neurosci. 26, 2830–2838 (2006).

    Article  CAS  Google Scholar 

  42. Rubenstein, R.C., Egan, M.E. & Zeitlin, P.L. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J. Clin. Invest. 100, 2457–2465 (1997).

    Article  CAS  Google Scholar 

  43. Singh, O.V. et al. Pharmacoproteomics of 4-phenylbutyrate-treated IB3–1 cystic fibrosis bronchial epithelial cells. J. Proteome Res. 5, 562–571 (2006).

    Article  CAS  Google Scholar 

  44. Rubenstein, R.C. & Zeitlin, P.L. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am. J. Respir. Crit. Care Med. 157, 484–490 (1998).

    Article  CAS  Google Scholar 

  45. Mroz, R.M., Noparlik, J., Chyczewska, E., Braszko, J.J. & Holownia, A. Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. J. Physiol. Pharmacol. 58 (suppl. 5): 453–460 (2007).

    PubMed  Google Scholar 

  46. Lei, D.C. et al. Episomal expression of wild-type CFTR corrects cAMP-dependent chloride transport in respiratory epithelial cells. Gene Ther. 3, 427–436 (1996).

    CAS  PubMed  Google Scholar 

  47. Devor, D.C., Bridges, R.J. & Pilewski, J.M. Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. Am. J. Physiol. Cell Physiol. 279, C461–C479 (2000).

    Article  CAS  Google Scholar 

  48. Butterworth, M.B., Edinger, R.S., Johnson, J.P. & Frizzell, R.A. Acute ENaC stimulation by cAMP in a kidney cell line is mediated by exocytic insertion from a recycling channel pool. J. Gen. Physiol. 125, 81–101 (2005).

    Article  CAS  Google Scholar 

  49. Myerburg, M.M. et al. Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis. J. Biol. Chem. 281, 27942–27949 (2006).

    Article  CAS  Google Scholar 

  50. Myerburg, M.M. et al. Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L932–L941 (2008).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank J.P. Clancy (University of Alabama, Birmingham) for the CFBE41o- expressing ΔF508 and the corrected CFBE41o- (WT-HBE41o-) expressing wild-type CFTR. This work was supported by US National Institutes of Health (NIH) grants HL79442 and GM42336 and aid from the Cystic Fibrosis Consortium to W.E.B.; NIH grant NS055781 to J.M.G.; NIH grants DK68196 and DK72506 and aid from the Cystic Fibrosis Consortium to R.A.F.; NIH grant UR98647 and aid from the Cystic Fibrosis Consortium to E.J.S.; NIH grant AG03197 to J.W.K.; NIH grant DK23567 to J.R.R.; NIH grant AG78594 to G.M.; and NIH grant DK075302 and aid from the Canadian Institutes of Health Research to G.L.L. D.M.H. has received support by fellowships from the Canadian Cystic Fibrosis Foundation and the Canadian Institutes of Health Research; D.H. was supported by a fellowship from the Friedreich's Ataxia Research Alliance. T.O. was supported by a fellowship from the Canadian Cystic Fibrosis Foundation.

Author information

Author notes

  1. Darren M Hutt and David Herman: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Cell Biology, The Scripps Research Institute, La Jolla, California, USA

    Darren M Hutt, Jeanne Matteson, Wendy Kellner, John R Yates III & William E Balch

  2. Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, USA

    David Herman, Ben Hoch, Joel M Gottesfeld & William E Balch

  3. Razavi Newman Center for Bioinformatics, Salk Institute for Biological Studies, La Jolla, California, USA

    Ana P C Rodrigues & Gerard Manning

  4. Department of Cell Biology and Physiology, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Sabrina Noel & Raymond A Frizzell

  5. Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Joseph M Pilewski

  6. Department of Chemistry, The Scripps Research Institute, La Jolla, California, USA

    Jeffery W Kelly

  7. Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California, USA

    Jeffery W Kelly

  8. Molecular Biophysics, University of Texas Southwestern Medical Center, Dallas, Texas, USA

    Andre Schmidt & Philip J Thomas

  9. Department of Biochemistry and Molecular Biology, Oregon Health and Sciences University, Portland, Oregon, USA

    Yoshihiro Matsumura & William R Skach

  10. Department of Cell and Developmental Biology, University of North Carolina, Chapel Hill, North Carolina, USA

    Martina Gentzsch

  11. Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina, USA

    John R Riordan

  12. Department of Cell Biology and Physiology, University of Alabama at Birmingham, Birmingham, Alabama, USA

    Eric J Sorscher

  13. Department of Physiology, McGill University, Montreal, Quebec, Canada

    Tsukasa Okiyoneda & Gergely L Lukacs

  14. Department of Chemical Physiology, The Scripps Research Institute, La Jolla, California, USA

    John R Yates III & William E Balch

  15. The Institute for Childhood and Neglected Diseases, The Scripps Research Institute, La Jolla, California, USA

    William E Balch

Authors
  1. Darren M Hutt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Herman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ana P C Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sabrina Noel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joseph M Pilewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jeanne Matteson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ben Hoch
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wendy Kellner
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jeffery W Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Andre Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Philip J Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yoshihiro Matsumura
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. William R Skach
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Martina Gentzsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. John R Riordan
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Eric J Sorscher
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Tsukasa Okiyoneda
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. John R Yates III
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Gergely L Lukacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Raymond A Frizzell
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Gerard Manning
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Joel M Gottesfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. William E Balch
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The manuscript was written by D.M.H. and W.E.B. D.M.H. from the W.E.B. laboratory was responsible for all western blot assays, iodide efflux data and analyses in CFBE41o- cells. W.K. assisted D.M.H. from the Balch laboratory in providing technical support for assays. D.H. from the J.M.G. laboratory performed all qRT-PCR analysis of CFTR and HDAC expression. A.P.C.R. from the G.M. laboratory performed the microarray analysis. S.N. from the R.A.F. laboratory performed all short-circuit current and western analyses in primary DF/DF-HBE cells, which were obtained through a collaboration with J.M.P. B.H. from the W.E.B. laboratory performed the ChIP analysis. A.S. from the P.J.T. laboratory performed the thermal melt curve analysis of CFTR-NBD1. Y.M. from the W.R.S. laboratory performed the in vitro translation analysis. M.G. performed the cell surface expression of DF508-CFTRextope in primary HBE cells. T.O. from the G.L.L. laboratory performed the cell surface stability analysis. E.J.S. performed the short-circuit analysis of TSA in CFBE41o- cells. J.R.R. performed the cell surface analysis. J.M. from the W.E.B. laboratory performed all pulse chase analyses. J.W.K. laboratory tested the effect of SAHA on L444P-glucoceribrosidase. W.E.B. directed all aspects of the project. R.A.F., P.J.T., E.J.S., W.R.S., J.R.R., M.G., J.M.G., G.L.L., J.R.Y. and G.M. supervised specific aspects of the project. W.E.B., R.A.F., P.J.T., E.J.S., W.R.S., J.R.R., M.G., J.M.G., G.L.L., J.R.Y. and G.M. provided financial support.

Corresponding author

Correspondence to William E Balch.

Ethics declarations

Competing interests

J.W.K. is a founder and W.E.B. is a scientific advisor for Proteostasis Therapeutics Inc. of Cambridge, Massachusetts, USA.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–11, Supplementary Table 1 and Supplementary Methods (PDF 8171 kb)

Supplementary Table 2

Microarray data for CFBE41o- cells following HDAC1 and 7 silencing. (XLS 4843 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hutt, D., Herman, D., Rodrigues, A. et al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol 6, 25–33 (2010). https://doi.org/10.1038/nchembio.275

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio.275

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing